<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03456154</url>
  </required_header>
  <id_info>
    <org_study_id>PPGO022</org_study_id>
    <nct_id>NCT03456154</nct_id>
  </id_info>
  <brief_title>Botox vs Occlusal Splint for Masseter Pain</brief_title>
  <official_title>Use of Botox Versus Conventional Treatment for Pain Decrease of Muscular Pain: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Pelotas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Pelotas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial will compare the standard treatment (occlusal splint) and
      botox for the treatment of face muscular pain in adults. Fifty patients will be invited and
      selected, and allocated to the experimental group, according to the randomization sequence
      previously performed. For the splint group, a rigid splint will be worn by the patient every
      night. For the botox group, 60u of botox will be injected in 3 regions of the masseter
      muscle. Patients will be assessed before the experiment, 3 and 6 months after the beginning
      of the study. Oral health related quality of life, pain, and cervical neck position will be
      evaluated. Paired t-test and chi-square will be used for statistical analysis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>VAS will be used to assess decrease of pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral health related quality of life</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>OHIP 14 questionnaire will be applied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cervical Position</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>Modifications of cervical vertebral column position will be assessed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain, Face</condition>
  <arm_group>
    <arm_group_label>Botox</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group patients will receive 3 injections of botox on each masseter (left and right), after randomization. This injection will be performed once, and the patient will be evaluated after 3 and 6 months after this day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Occlusal splint</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group patients will receive an occlusal splint, which will be manufactured after taking their full mouth impression. This appliance has to be worn everyday, for 6 months, at night.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botox Injectable Product</intervention_name>
    <description>60u will be used at 3 sites of masseter muscle, on each side of the face</description>
    <arm_group_label>Botox</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Occlusal splint</intervention_name>
    <description>In this group patients will receive an occlusal splint which will be worn everyday for 6 months at night.</description>
    <arm_group_label>Occlusal splint</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 18 and 70 years old;

          -  at least 20 teeth in the mouth;

          -  occlusal stability;

          -  presenting pain in face muscles.

        Exclusion Criteria:

          -  Angle's Class III

          -  Kennedy's Class II or I removable partial denture wearer;

          -  Complete denture wearer;

          -  Individuals that have taken any anti inflammatory drugs in the last 3 months;

          -  Individuals with temporomandibular joint disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Federal University of Pelotas</name>
      <address>
        <city>Pelotas</city>
        <state>Rio Grande Do Sul</state>
        <zip>96015560</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maximiliano Cenci, PhD</last_name>
      <phone>555332256741</phone>
      <phone_ext>135</phone_ext>
      <email>cencims@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Tatiana Cenci, PhD</last_name>
      <phone>5553</phone>
      <email>tatiana.cenci@ufpel.tche.br</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Pelotas</investigator_affiliation>
    <investigator_full_name>Maximiliano Sergio Cenci</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facial Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
    <mesh_term>Salicylic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

